Department of General medicine
Where Expertise Meets Innovation in Every Specialty.
Department of General medicine caters to general medical problems & medical emergencies.
- It links all departments & specialties in the hospital; it is managed by an excellent & competent group of doctors which includes consultants, senior residents & post graduate trainers.
- We have teaching programs for both undergraduate medical (MBBS) as well as post graduate (MD, General Medicine) students.
- The main role of this department is to diagnose, treat appropriately and establish the patient on the road to recovery, focusing on the health of the whole person containing physical, psychological & social aspects.
- We deal with medical conditions such as diabetes mellitus, high blood pressure, heart diseases, Rheumatism, asthma etc.
We provide services that include-
- Critical care
- Intensive care treatment & management of critically ill/compromised patients, infectious diseases, drug overdose, poisoning and other medical emergencies like septicemia, diabetic ketoacidosis, shock of any kind, meningitis, pneumonia etc.
- Management of chronic disease
- Management of infectious diseases [Malaria, Typhoid fever, tuberculosis, Dengue, influenza]
- Management of drug overdose & poisoning
Dr. Mithun Somaiah
Professor and Head
Department of General medicine
FACULTY
Ongoing Research Activities Department of General Medicine
Faculty
- A Prospective, randomized, open label, comparative study of efficacy and safety evaluation of Saberry® against Metformin 500mg in newly diagnosed patients of type 2 diabetes mellitus associated with dyslipidemia. (Ongoing)
- A Randomized, Double-blind, Placebo controlled study to evaluate clinical safety of Pterostilbene in healthy volunteers. (Ongoing)
- Single blind, randomized comparative study assessing clinical equivalence of two polyglycolic acid fast absorbing suture brands, Truglyde Fast® and Safil Quick®, on maternal morbidity experienced by women following episiotomy repair. (Ongoing)
- “Multicenter, Single-dose, Randomized, Parallel Arm Two-treatment Bioequivalence Study of Mylan’s Iron Dextran (50 mg/mL) versus Allergan’s INFeD® (50 mg/mL) Following a Single Intravenous Injection in Patients with Iron Deficiency Anemia” (Started Screening)
- A randomised, double-blind, double-dummy, parallel-group, multi-centre, active-controlled study to evaluate efficacy and safety of fixed dose combination of remogliflozin etabonate and teneligliptin in subjects with type-2 diabetes mellitus (Yet to Start)
